Literature DB >> 11331421

Interaction of alpha-synuclein and synphilin-1: effect of Parkinson's disease-associated mutations.

H Kawamata1, P J McLean, N Sharma, B T Hyman.   

Abstract

alpha-Synuclein is a major component of Lewy bodies, a neuropathological feature of Parkinson's disease. Two alpha-synuclein mutations, Ala53Thr and Ala30Pro, are associated with early onset, familial forms of the disease. Recently, synphilin-1, a protein found to interact with alpha-synuclein by yeast two hybrid techniques, was detected in Lewy bodies. In this study we report the interaction of alpha-synuclein and synphilin-1 in human neuroglioma cells using a sensitive fluorescence resonance energy transfer technique. We demonstrate that the C-terminus of alpha-synuclein is closely associated with the C-terminus of synphilin-1. A weak interaction occurs between the N-terminus of alpha-synuclein and synphilin-1. The familial Parkinson's disease associated mutations of alpha-synuclein (Ala53Thr and Ala30Pro) also demonstrate a strong interaction between their C-terminal regions and synphilin-1. However, compared with wild-type alpha-synuclein, significantly less energy transfer occurs between the C-terminus of Ala53Thr alpha-synuclein and synphilin-1, suggesting that the Ala53Thr mutation alters the conformation of alpha-synuclein in relation to synphilin-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331421     DOI: 10.1046/j.1471-4159.2001.00301.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway.

Authors:  Jochen Klucken; Anne-Maria Poehler; Darius Ebrahimi-Fakhari; Jacqueline Schneider; Silke Nuber; Edward Rockenstein; Ursula Schlötzer-Schrehardt; Bradley T Hyman; Pamela J McLean; Eliezer Masliah; Juergen Winkler
Journal:  Autophagy       Date:  2012-05-01       Impact factor: 16.016

2.  The prion hypothesis of Parkinson's disease.

Authors:  Yaping Chu; Jeffrey H Kordower
Journal:  Curr Neurol Neurosci Rep       Date:  2015-05       Impact factor: 5.081

3.  Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.

Authors:  Esti Liani; Allon Eyal; Eyal Avraham; Revital Shemer; Raymonde Szargel; Daniela Berg; Antje Bornemann; Olaf Riess; Christopher A Ross; Ruth Rott; Simone Engelender
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-02       Impact factor: 11.205

4.  The biochemical basis of Parkinson's disease: the role of catecholamine o-quinones: a review-discussion.

Authors:  John Smythies; Angela De Iuliis; Lucia Zanatta; Lauro Galzigna
Journal:  Neurotox Res       Date:  2002-02       Impact factor: 3.911

Review 5.  SUMO and Parkinson's disease.

Authors:  Katrin Eckermann
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

6.  Nicotine suppresses Parkinson's disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels.

Authors:  Angel Carvajal-Oliveros; Carmen Domínguez-Baleón; Rafaella V Zárate; Jorge M Campusano; Verónica Narváez-Padilla; Enrique Reynaud
Journal:  Sci Rep       Date:  2021-05-05       Impact factor: 4.379

Review 7.  S-nitrosylation of the thioredoxin-like domains of protein disulfide isomerase and its role in neurodegenerative conditions.

Authors:  Myra E Conway; Matthew Harris
Journal:  Front Chem       Date:  2015-04-16       Impact factor: 5.221

8.  Splicing variants of porcine synphilin-1.

Authors:  Knud Larsen; Lone Bruhn Madsen; Leila Farajzadeh; Christian Bendixen
Journal:  Meta Gene       Date:  2015-06-02

9.  Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy.

Authors:  Jia-Zhen Wu; Mustafa Ardah; Caroline Haikal; Alexander Svanbergsson; Meike Diepenbroek; Nishant N Vaikath; Wen Li; Zhan-You Wang; Tiago F Outeiro; Omar M El-Agnaf; Jia-Yi Li
Journal:  Transl Neurodegener       Date:  2019-06-15       Impact factor: 8.014

10.  Potential Role of Caffeine in the Treatment of Parkinson's Disease.

Authors:  Mohsin H K Roshan; Amos Tambo; Nikolai P Pace
Journal:  Open Neurol J       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.